This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Ghent. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Gert Smans and a Peloruside-Inspired Therapeutic Invention
Introduction
Gert Smans is an inventor associated with Rheinfelden, Germany. His patent work concerns potential therapeutic compounds inspired by peloruside, a naturally occurring substance.
Latest Patents
The supplied information lists one patent for Gert Smans: “Peloruside Analogs.” The invention describes phenyl analogs of peloruside intended for treating diseases caused or influenced by microtubule stability, including proliferative diseases. According to the patent description, these analogs are easier to synthesize than peloruside, potentially enabling production in larger quantities for therapeutic use. The listed patent count is 1 patent.
Career Highlights
The provided information associates Smans with the University of Ghent. His listed invention reflects research into developing more accessible, synthetically practical compounds for potential medical applications.
Collaborations
The supplied data names Dries Van Den Bossche and Jelle Cornelus as Smans’s coworkers. It does not specify their roles in the patent or the research.
Conclusion
Gert Smans’s listed patent explores easier-to-synthesize peloruside analogs as potential treatments for diseases involving microtubule stability, highlighting the therapeutic possibilities of this research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile